The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Biosyent Inc up $0.01

Biosyent Inc is up today by $0.01 or 0.10% to $9.54. Shares have lost 1.85% for the last five days, but have gained 29.80% over the last 52 weeks. This security has outperformed the S&P TSX by 24.39% during the last year.

Key company metrics

  • Trailing P/E28.92×
  • P/E 1 year forward27.23×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.33
Updated January 16 12:15 PM EST. Delayed by at least 15 minutes.
S&P TSX0.34%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Total other revenue--------
Total revenue5645
Gross profit4434
Total cost of revenue1111
Total operating expense4433
Selling / general / administrative2222
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total----00
Operating income2212
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax2212
Income after tax1211
Income tax, total0000
Net income1211
Total adjustments to net income--------
Net income before extra. items1211
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1211
Inc. avail. to common incl. extra. items1211
Diluted net income1211
Dilution adjustment0000
Diluted weighted average shares15151515
Diluted EPS excluding extraordinary itemsvalue per share0.
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.